NeuroWatch Funding: How Much Did They Raise & Key Investors

How Much Did NeuroWatch Raise?
Funding & Key Investors

NeuroWatch has secured $110K in total capital, with its most recent financing round bringing in $110K. This significant backing underscores the company's established position in the intraoperative neuromonitoring (IONM) sector, particularly within the context of large-scale late-stage funding and a major strategic investment.

What is NeuroWatch?

NeuroWatch

Hospitals & Physicians Clinics

Medical Practice Management

Healthcare Services

NeuroWatch is a prominent provider of intraoperative neuromonitoring (IONM) services, crucial for safeguarding nerve function during complex brain and spinal surgeries. The company leverages a team of certified technologists and advanced computerized equipment to deliver real-time monitoring, enabling surgeons to make critical adjustments and enhance patient safety. Their expertise is indispensable for a wide array of surgical procedures, positioning NeuroWatch as a vital partner in operating rooms nationwide.

How much funding has NeuroWatch raised?

NeuroWatch has raised a total of $110K across 1 funding round:

2021

Debt

$110K

Debt (2021): $110K with participation from PPP

What's next for NeuroWatch?

The substantial capital infusion, characterized as large-scale late-stage funding and a major strategic investment, signals NeuroWatch's readiness for significant expansion and operational enhancement. This financial momentum is likely to fuel advancements in their technological capabilities, broader market penetration, and potentially the scaling of their specialized IONM services. The company is poised to further solidify its leadership in a critical segment of surgical care, driven by strategic financial backing.

See full NeuroWatch company page

See More Financial Insights